BioSpace News Archive

Business

Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2023

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter financial results on Monday, May 8, 2023, after the close of the U.S. financial markets.

April 25, 2023

·

2 min read

Biotech Beach

Sentynl Therapeutics Announces Presentation at 2023 Pharmaceutical Compliance Congress

Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases, will participate in the 2023 Pharmaceutical Compliance Congress hosted by Informa Connect Life Sciences on Thursday, April 27, at 2 p.m. ET.

April 25, 2023

·

2 min read

BioMidwest

New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain

SPR® Therapeutics announced the introduction of the SPRINT extensa XT System with bimodal peripheral nerve stimulation (PNS), designed to deliver a comprehensive approach to the alleviation of pain by treating dual nerve targets with synergistic stimulation modalities.

April 25, 2023

·

3 min read

BioMidwest

New Studies on Convergent Genomics’ Urine Test for Bladder Cancer to be Presented at 2023 American Urological Association (AUA) Annual Meeting

Convergent Genomics announced UroAmp, the company’s genomic urine test that uses next-generation DNA sequencing and machine learning to detect and monitor for bladder cancer, will be the subject of two new studies being presented at the 2023 American Urological Association (AUA) Annual Meeting in Chicago.

April 25, 2023

·

3 min read

Drug Development

Prilenia Shares Preliminary Topline Results from Phase 3 PROOF-HD Clinical Trial in Huntington’s Disease and Data from Phase 2 HEALEY ALS Platform Trial of Pridopidine at the 75th American Academy of Neurology (AAN) Annual Meeting

Prilenia Therapeutics B.V. today announced preliminary topline results of its Phase 3 PROOF-HD clinical study evaluating the safety and efficacy of pridopidine in individuals with Huntington’s disease (HD).

April 25, 2023

·

9 min read

BioCapital

AUA, SUFU Release an Amendment to the Female Stress Urinary Incontinence Guideline

The American Urological Association, in partnership with the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, released the 2023 clinical practice guideline amendment for the surgical treatment of female stress urinary incontinence.

April 25, 2023

·

2 min read

VySpine Announces FDA Clearance for UniVy OsteoVy-Ti Cervical IBF with NanoVy-HA

VySpine announced today that it has received 510(k) clearance from the FDA for its UniVy OsteoVy-Ti NanoVy-HA Cervical IBF System which is indicated for intervertebral body fusion for use at one level in the cervical spine, from C3 to T1, for the treatment of degenerative disc disease (DDD).

April 25, 2023

·

2 min read

Business

Health Catalyst to Announce First Quarter 2023 Operating Results and Host Conference Call on Tuesday, May 9, 2023

Health Catalyst, Inc., a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2023 operating results on Tuesday, May 9, 2023, after market close.

April 25, 2023

·

1 min read

Business

Halozyme To Report First Quarter 2023 Financial and Operating Results

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced it will release its first quarter 2023 financial and operating results on Tuesday, May 9, 2023, following the close of trading.

April 25, 2023

·

2 min read

Biotech Beach

SYNTR HEALTH TECHNOLOGIES ANNOUNCES POSITIVE DATA FROM FACIAL FAT TRANSFER CLINICAL STUDY USING THEIR FDA CLEARED SYNTRFUGE™ SYSTEM

Syntr Health Technologies, Inc. announces positive interim results from its post-market facial fat transfer clinical study.

April 25, 2023

·

2 min read